Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display & Cocktail

40P - The exosomes transfer the acquired resistance of MCF-7 breast cancer cells to rapamycin and tamoxifen

Date

02 Mar 2020

Session

Poster Display & Cocktail

Presenters

Alexander Scherbakov

Citation

Annals of Oncology (2020) 31 (suppl_1): S17-S18. 10.1016/annonc/annonc81

Authors

A.M. Scherbakov, Y. Shchegolev, D. Sorokin, M. Krasil’nikov

Author affiliations

  • Department Of Experimental Tumor Biology, N.N. Blokhin National Medical Research Center of Oncology, 115522 - Moscow/RU
More

Resources

Abstract 40P

Resistance to targeted therapy is one of the important problems in oncology. The main purpose of the work was to study the exosomes involvement in the progression of the resistance of breast cancer cells.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings